Sunday, October 22, 2017 12:00:01 AM
Has factual information about the refining business, or MMEX prevented you from trading MMEX shares?
I thought not.
MMEX fundamentals are an across the board failure - toxic debt structured as tradable shares, a business plan so flawed it would get an undergraduate failed out of even the most basic course, and any individual with experience in the field would find it laughable. That is MMEX.
It has everything. A web site, a bunch of rehashed/regurgitated empty and meaningless PR, affiliations with a few legitimate companies, and a few who have no industry track record. Lots of cheerleaders, most devoid of facts or substantive data supporting an investment in a legitimate business.
It has a bunch of shady principles, who have no verifiable track record in the refining business. MMEX has everything!
I forgot to mention the worthless MMEX permit by regulation, a clerical/administrative document than had a nominal $100 purchase price (the company didn't disclose what it paid to have the application prepared).
A land deal for $10 and "other consideration." And let's not forget MMEX's upcoming ground-breaking ceremony. I am bringing a dump-truck load of money to that party.
Recent MMEX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:51:51 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/08/2024 02:30:21 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/03/2024 01:18:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 03:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 04:48:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 06:42:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/11/2023 08:50:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/17/2023 08:55:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM